Table 2.

Fibromyalgia and severity measures according to WS pain and criteria categories. Values are mean (SD) unless otherwise specified.

VariablesWPI 3–6 and SSS ≥ 9WPI ≥ 7 and SSS ≥ 5AllWS PainNot WS Pain
Subjects in category, n343466850114700311
WPI4.6 (1.1)12.9 (4.3)12.3 (4.7)12.8 (4.5)6.0 (2.3)
SSS9.7 (0.8)7.7 (2.0)7.8 (2.0)7.8 (2.0)8.5 (1.9)
PSD14.3 (1.4)20.6 (5.2)20.2 (5.3)20.5 (5.2)14.5 (2.1)
Age, yrs52.3 (12.6)56.0 (13.0)55.8 (13.0)55.9 (13.1)53.4 (12.6)
Male, %7.310.6*10.410.58.7*
College graduate, %33.830.6*30.830.635*
HAQ, 0–31.2 (0.6)1.5 (0.6)1.5 (0.6)1.5 (0.6)1.2 (0.6)
Pain, 0–105.7 (2.5)6.4 (2.2)6.3(2.2)6.4 (2.2)5.5 (2.6)
Global severity, 0–105.6 (2.2)5.9 (2.1)5.9 (2.1)5.9 (2.1)5.3 (2.2)
PCS, SF-3632.7 (8.3)28.9 (7.8)29.1 (7.9)28.9 (7.7)32.5 (8.9)
MCS, SF-3634.6 (10.6)39.5 (11.5)39.1 (5.0)39.3 (11.5)37.5 (11.2)
PHQ-1513.5 (3.1)13.5 (4.7)*13.5 (4.6)13.5 (4.6)12.4 (3.8)*
PHQ-4 score5.1 (3.6)4.3 (3.5)*4.4 (3.5)4.4 (3.6)4.9 (3.5)*
  • The low WPI and high WPI groups (columns 2 and 3) are significantly different from each other at p < 0.5, except where flagged with asterisks (*). WS Pain and Not WS Pain groups (columns 5 and 6) are significantly different from each other at p < 0.5, except where flagged with asterisks (*). WS pain: widespread pain; WPI: Widespread Pain Index; SSS: Symptom Severity Scale; PSD: Polysymptomatic Distress Scale; HAQ: Health Assessment Questionnaire; PCS: physical component summary; SF-36: Medical Outcomes Study Short Form-36; MCS: mental component summary; PHQ-15: Patient Health Questionnaire 15; PHQ-4: Patient Health Questionnaire 4.